Reframing healthcare as an engine of economic resilience

This month, thousands of policy makers, clinicians, and partners across the public and private sectors are meeting under the banner of this year’s theme, From Crisis to Resilience: Innovating for Health.

There is much to build on. Rapid advances in early diagnostics, digital tools, and targeted treatments are transforming our ability to manage chronic conditions and prevent acute health crises before they overwhelm healthcare systems.

Yet the pressure on where governments choose to direct their financial resources  is more challenging  than ever.

Rising disease burdens, aging populations, and severe workforce shortages are pushing traditional, hospital-centric care models to their limits.

Navigating these challenges requires continued scientific progress. But it also requires a fundamental shift in how we measure the value of health spending - and the economic return it creates.

The true cost of ill health: Looking beyond immediate budgets

When healthcare budgets are stretched, the instinct of governments is often to focus on the immediate cost of a test, a treatment, or a medicine. But the real cost of ill health extends far beyond the clinical bill.

It includes lost working hours, unpaid care provided by family members, reduced productivity, and early exit from the workforce. When a person’s health collapses, their contribution to their family and society collapses too.

At WHS this year, Roche leaders are contributing directly to these critical policy discussions:

While health priorities vary by country, our path forward is clear: we have the science, technology, and evidence. By collaborating across sectors and an all of government approach, we can unlock the full value of health investments, benefiting individuals, health systems, and economies alike.